Publications

Journals

• Wren AM; Seal LJ; Cohen MA; Brynes AE; Frost GS; Murphy KG; Dhillo WS; Ghatei MA; et alBloom SR. (1 Dec 2001). Ghrelin enhances appetite and increases food intake in humans. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 86:5992-5995. Author weblink DOI.
• Batterham RL; Cowley MA; Small CJ; Herzog H; Cohen MA; Dakin CL; Wren AM; Brynes AE; et alLow MJ; Ghatei MA; Cone RD; Bloom SR. (8 Jul 2004). Does gut hormone PYY3-36 decrease food intake in rodents? Reply. NATURE. 430. Author weblink DOI.
• Wren AM; Small CJ; Ward HL; Murphy KG; Dakin CL; Taheri S; Kennedy AR; Roberts GH; et alMorgan DG; Ghatei MA; Bloom SR. (Nov 2000). The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology. 141:4325-4328.
• Abbott CR; Rossi M; Wren AM; Murphy KG; Kennedy AR; Stanley SA; Zollner AN; Morgan DG; et alMorgan I; Ghatei MA; Small CJ; Bloom SR. (Aug 2001). Evidence of an orexigenic role for cocaine- and amphetamine-regulated transcript after administration into discrete hypothalamic nuclei. Endocrinology. 142:3457-3463.
• Wren AM; Small CJ; Abbott CR; Dhillo WS; Seal LJ; Cohen MA; Batterham RL; Taheri S; et alStanley SA; Ghatei MA; Bloom SR. (Nov 2001). Ghrelin causes hyperphagia and obesity in rats. Diabetes. 50:2540-2547. Open Access copy.
• Wren AM; Seal LJ; Cohen MA; Brynes AE; Frost GS; Murphy KG; Dhillo WS; Ghatei MA; et alBloom SR. (Dec 2001). Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab. 86:5992. Open Access copy.
• Batterham RL; Cowley MA; Small CJ; Herzog H; Cohen MA; Dakin CL; Wren AM; Brynes AE; et alLow MJ; Ghatei MA; Cone RD; Bloom SR. (8 Aug 2002). Gut hormone PYY(3-36) physiologically inhibits food intake. Nature. 418:650-654. DOI.
• Wren AM; Small CJ; Abbott CR; Jethwa PH; Kennedy AR; Murphy KG; Stanley SA; Zollner AN; et alGhatei MA; Bloom SR. (Nov 2002). Hypothalamic actions of neuromedin U. Endocrinology. 143:4227-4234. Open Access copy.
• Wren AM; Small CJ; Fribbens CV; Neary NM; Ward HL; Seal LJ; Ghatei MA; Bloom SR. (Nov 2002). The hypothalamic mechanisms of the hypophysiotropic action of ghrelin. Neuroendocrinology. 76:316-324.
• Turner JJ; Wren AM; Jackson JE; Thakker RV; Meeran K. (Dec 2002). Localization of gastrinomas by selective intra-arterial calcium injection. Clin Endocrinol (Oxf). 57:821-825.
• Abbott CR; Kennedy AR; Wren AM; Rossi M; Murphy KG; Seal LJ; Todd JF; Ghatei MA; et alSmall CJ; Bloom SR. (Sep 2003). Identification of hypothalamic nuclei involved in the orexigenic effect of melanin-concentrating hormone. Endocrinology. 144:3943-3949.
• Neary NM; Small CJ; Wren AM; Lee JL; Druce MR; Palmieri C; Frost GS; Ghatei MA; et alCoombes RC; Bloom SR. (Jun 2004). Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J Clin Endocrinol Metab. 89:2832-2836. DOI.
• Druce MR; Wren AM; Park AJ; Milton JE; Patterson M; Frost G; Ghatei MA; Small C; et alBloom SR. (Sep 2005). Ghrelin increases food intake in obese as well as lean subjects. Int J Obes (Lond). 29:1130-1136. DOI.
• Wynne K; Park AJ; Small CJ; Patterson M; Ellis SM; Murphy KG; Wren AM; Frost GS; et alMeeran K; Ghatei MA; Bloom SR. (Aug 2005). Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial. Diabetes. 54:2390-2395.